Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...
News-Medical.Net on MSN
Breakthrough could offer a new therapeutic option for stopping diabetes-induced complications
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...
In the MIROCALS trial, Gilbert Bensimon and colleagues1 showed that low-dose interleukin-2 (IL-2) added to riluzole did not significantly reduce mortality in an unadjusted analysis of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback